ES482073A2 - Mejoras en la patente principal por procedimiento de obten- cion de 3-metil-lactosa utilizable para la evaluacion de la lactosa intestinal. - Google Patents

Mejoras en la patente principal por procedimiento de obten- cion de 3-metil-lactosa utilizable para la evaluacion de la lactosa intestinal.

Info

Publication number
ES482073A2
ES482073A2 ES482073A ES482073A ES482073A2 ES 482073 A2 ES482073 A2 ES 482073A2 ES 482073 A ES482073 A ES 482073A ES 482073 A ES482073 A ES 482073A ES 482073 A2 ES482073 A2 ES 482073A2
Authority
ES
Spain
Prior art keywords
lactose
methyl
translation
evaluation
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES482073A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consejo Superior de Investigaciones Cientificas CSIC
Original Assignee
Consejo Superior de Investigaciones Cientificas CSIC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Superior de Investigaciones Cientificas CSIC filed Critical Consejo Superior de Investigaciones Cientificas CSIC
Priority to ES482073A priority Critical patent/ES482073A2/es
Publication of ES482073A2 publication Critical patent/ES482073A2/es
Expired legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)

Abstract

Mejoras en la patente principal nº. 478.590 por "Procedimiento de obtención de 3-metil-lactosa utilizable para la evaluación de la lactosa intestinal", caracterizadas porque la metilación del heptabenzoato obtenido por benzoilación de alfa-lactosa se realiza empleando como agente metilante trifluorometan-sulfanato de metilo en presencia de una 2,6-di-t-butil piridina, dando lugar a la 1, 2, 6, 2'', 3'', 4'', 6''-hepta-O- benzoil-3-O-metil lactosa.
ES482073A 1979-06-29 1979-06-29 Mejoras en la patente principal por procedimiento de obten- cion de 3-metil-lactosa utilizable para la evaluacion de la lactosa intestinal. Expired ES482073A2 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES482073A ES482073A2 (es) 1979-06-29 1979-06-29 Mejoras en la patente principal por procedimiento de obten- cion de 3-metil-lactosa utilizable para la evaluacion de la lactosa intestinal.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES482073A ES482073A2 (es) 1979-06-29 1979-06-29 Mejoras en la patente principal por procedimiento de obten- cion de 3-metil-lactosa utilizable para la evaluacion de la lactosa intestinal.

Publications (1)

Publication Number Publication Date
ES482073A2 true ES482073A2 (es) 1980-04-01

Family

ID=8478566

Family Applications (1)

Application Number Title Priority Date Filing Date
ES482073A Expired ES482073A2 (es) 1979-06-29 1979-06-29 Mejoras en la patente principal por procedimiento de obten- cion de 3-metil-lactosa utilizable para la evaluacion de la lactosa intestinal.

Country Status (1)

Country Link
ES (1) ES482073A2 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9128100B2 (en) 2011-01-14 2015-09-08 Venter Pharma, S.L. Non-invasive diagnostic method for the evaluation of intestinal lactase deficiency (hypolactasia)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9128100B2 (en) 2011-01-14 2015-09-08 Venter Pharma, S.L. Non-invasive diagnostic method for the evaluation of intestinal lactase deficiency (hypolactasia)
US9529000B2 (en) 2011-01-14 2016-12-27 Venter Pharma, S.L. Non-invasive diagnostic method for the evaluation of intestinal lactase deficiency (hypolactasia)

Similar Documents

Publication Publication Date Title
JPS53141206A (en) Process for preparing lower molecular weigh polyhydroxy compound
GB1540024A (en) Process for preparing 1,4:3,6-dianhydro-d-glucitol 2-nitrate
YU41538B (en) Process for obtaining condensed pyramidine derivatives
ES461415A2 (es) Procedimiento para la preparacion de vacunas acelulares.
DE3060568D1 (en) Process for the preparation of 4,5-perfluoro-1,3-dioxolanes
YU92080A (en) Process for obtaining 5-substituted pyranones
NL183601C (nl) Koppeling voor pijpen of dergelijke staafvormige onderdelen.
IT1172185B (it) Composizione particolarmente per la vande vaginali
IT1084127B (it) Giunto per mobili
RO78090A (ro) Procedeu pentru prepararea unor derivati de 1,2,3-tiadiazol-5-il uree
ES482073A2 (es) Mejoras en la patente principal por procedimiento de obten- cion de 3-metil-lactosa utilizable para la evaluacion de la lactosa intestinal.
RO84583A (ro) Procedeu pentru prepararea unor derivati de piranona
BG33292A3 (en) Method for obtaining of penamsulphooxide derivatives
YU41738B (en) Process for obtaining 1,2,4-oxadiazoline-5-one derivatives
ES478590A1 (es) Procedimiento de obtencion de 3-metil-lactosa utilizable pa-ra la evaluacion de la lactasa intestinal.
YU40338B (en) Process for obtaining substituted hexahydro-benzopirano(3,2-c) pyridines
BG40808A3 (en) Method for preparing derivatives of pyrrolidine
YU57478A (en) Process for obtaining 1,2,3-thiadiazoline-2-ide derivatives
BG41128A3 (en) Method for prepparing intermediary compounds for preparation of benzothiazine- carboxamides
OA06620A (fr) Procédé de préparation de nouveaux dérivés de décahydroquinoléinol.
BG33281A3 (en) Method for obtaining of2- (2- chlorine- 4- cyclopropylphenylimino)- imidazolidine
ES459352A2 (es) Mejoras en las cafeteras de hidrocompresion.
ES246205U (es) Manta perfeccionada
ES467321A1 (es) Procedimiento para la preparacion de 5-(indol-3-ilmetilen)- 1,3-dimetil-2-metilimino-4imidazolidinona opcionalmente 6- alquil sustituida.
EP0000473B1 (en) Process for preparing aminoglycoside derivatives, novel derivatives obtained and pharmaceutical compositions containing such derivatives

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20170707